Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Anti-Zoster Drug Prevents Shingles in Lupus Patients on Anifrolumab - about 2 months ago
2	Kristen Monaco MedPage Today	Imcivree Label Expanded; Weight Loss With Weekly Injection; Kidney Donation Chain - 2 months ago Clonazepam Recall Expands; Lipid Depression Screening; Period Pain and Depression - 3 months ago Long-Term Data Support Efficacy, Safety of New Schizophrenia Drug - 4 months ago Year in Review: Tardive Dyskinesia - 4 months ago Fanapt OK'd for Bipolar; First Depression App Cleared; Keto Diet for Schizophrenia - 11 months ago
3	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Beckley Psytech announces positive results for ELE-101 in depression trial - 2 months ago European Commission grants orphan drug designation for Vivet’s VTX-806 - 6 months ago
4	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy - 4 months ago Extended Antiviral Treatment Could Benefit Ocular Shingles Vision Outcomes - 4 months ago Jazz Pharmaceuticals Submits Biologics License Application for Zanidatamab to Treat Biliary Tract Cancer - 11 months ago
5	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Oral Sulopenem Etzadroxil and Probenecid for Uncomplicated Urinary Tract Infections - 4 months ago FDA Accepts NDA and Priority Review Application for Vimseltinib in Tenosynovial Giant Cell Tumors - 6 months ago FDA Approves Amivantamab-Vmjw and Lazertinib for First-Line Treatment of NSCLC - 6 months ago FDA Approves Cerliponase Alfa for Expanded Indication of CLN2 Disease - 7 months ago Brentuximab Vedotin Shows 37% Reduction in Risk of Death for DLBCL - 8 months ago Novel Drugs Targeting Different Pathways Show Promise in Schizophrenia - 11 months ago FDA Expands Label for Bempedoic Acid to Reduce Cardiovascular Risk, With or Without Statins - 11 months ago FDA Approves Rybrevant as First-Line Treatment for NSCLC - 12 months ago FDA Grants Fast Track Designation to Bepirovirsen for Chronic Hepatitis B - about 1 year ago Biosimilar SB8 Is Comparable to Bevacizumab for Non–Small Cell Lung Cancer - about 1 year ago FDA Approves Berdazimer Topical Gel as First Treatment for Molluscum Contagiosum - about 1 year ago FDA Approves Belzutifan for Treatment of Advanced Renal Cell Carcinoma - about 1 year ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - about 1 year ago FDA Approves Capivasertib With Fulvestrant for PIK3CA/ALT1/PTEN Alterations Breast Cancer - over 1 year ago Brexpiprazole Demonstrates Clinically Meaningful Improvements for Agitation Due to Alzheimer Disease - over 1 year ago FDA Grants Priority Review to New Drug Application for Belzutifan for Advanced Renal Cell Carcinoma - over 1 year ago
6	Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location medical reporting	Stroke Survivors Still Prescribed a 'Concerning' Amount of Benzos - 4 months ago Expanded Label Officially Makes Bempedoic Acid a CVD Prevention Medication - 11 months ago RNA Silencer Zilebesiran: Infrequent Injections Bring Down BP - about 1 year ago
7	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Continuous Parkinson's Disease Therapy Wins FDA Nod - 4 months ago ALS Therapy to Be Pulled From the Market, Drugmaker Says - 11 months ago Alzheimer's Supplements Fail Compared With Generic Drugs - 12 months ago Can a GLP-1 Agonist Improve Parkinson's Symptoms? - about 1 year ago
8	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 8 months ago Long-Acting Injectable Helped Adults With Schizophrenia Remain Relapse-Free - over 1 year ago
9	Natasha Lomas TechCrunch Journalist. Climber-in-training. Owns cats. Barcelona and London journalismclimbing	Neurotech startup Neurovalens gets FDA clearance for noninvasive anxiety treatment - 11 months ago
10	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about a failed schizophrenia drug trial, a Pfizer cancer drug, and more - 12 months ago STAT+: Pharmalittle: We’re reading about slow uptake of an Alzheimer’s drug, an opioid lawsuit, and more - about 1 year ago STAT+: Pharmalittle: Bristol Myers to buy schizophrenia-drug maker; Servier found guilty of fraud - about 1 year ago STAT+: Pharmalittle: Wegovy cuts heart attack risk in milestone trial; AstraZeneca prioritizes U.S. for RSV drug amid surge - over 1 year ago

Journalists covering valbenazine